35 results on '"Hayden, Frederick G"'
Search Results
2. Comment to: Baloxavir efficacy in North American Adults
3. Antivirals for influenza: Historical perspectives and lessons learned
4. Influenza in the acute hospital setting
5. Influenza virus neuraminidase inhibitors
6. Prevention and treatment of influenza in immunocompromised patients
7. Herpesvirus infections in burn patients
8. Current Research on Influenza and other Respiratory Viruses: II International Symposium
9. First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4–6, 1998
10. Resistant influenza A viruses in children treated with oseltamivir: descriptive study
11. Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection
12. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus.
13. The search for therapeutic options for Middle East Respiratory Syndrome (MERS).
14. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12–13 February 2009
15. Neuraminidase inhibitors: assessment of limitations to greater therapeutic use
16. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
17. Towards improving clinical management of Middle East respiratory syndrome coronavirus infection.
18. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses
19. Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial.
20. Antivirals targeting the polymerase complex of influenza viruses.
21. Anti-infectives: new trends, new approaches
22. Drug resistance and influenza pandemics.
23. Drug resistance and influenza pandemics.
24. Antiviral resistance in clinical practice
25. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
26. Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model
27. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
28. Combination antiviral therapy for respiratory virus infections
29. Design, recruitment, and microbiological considerations in human challenge studies.
30. Antiviral combinations for severe influenza.
31. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.
32. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
33. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference.
34. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
35. Ebola virus disease: an update on post-exposure prophylaxis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.